Abstract
This work presents a recently-patented small arms concept demonstrator that substantially reduces the recoil force transmitted to the user during operation. In live-fire tests, this invention produced recoil forces that were approximately 84% to 91% less than those produced by the M240 machine gun. To achieve such recoil force reduction, this invention includes design features to reduce the propellant gas contribution to recoil force and cancel the moving internal component contribution to recoil force.
Keywords: Gun, inertia, mechanism, momentum, recoil reduction, small arms
Recent Patents on Mechanical Engineering
Title:A Concept Demonstrator for Small Arms Recoil Reduction
Volume: 6 Issue: 2
Author(s): Kevin Russell
Affiliation:
Keywords: Gun, inertia, mechanism, momentum, recoil reduction, small arms
Abstract: This work presents a recently-patented small arms concept demonstrator that substantially reduces the recoil force transmitted to the user during operation. In live-fire tests, this invention produced recoil forces that were approximately 84% to 91% less than those produced by the M240 machine gun. To achieve such recoil force reduction, this invention includes design features to reduce the propellant gas contribution to recoil force and cancel the moving internal component contribution to recoil force.
Export Options
About this article
Cite this article as:
Russell Kevin, A Concept Demonstrator for Small Arms Recoil Reduction, Recent Patents on Mechanical Engineering 2013; 6 (2) . https://dx.doi.org/10.2174/2212797611306020006
DOI https://dx.doi.org/10.2174/2212797611306020006 |
Print ISSN 2212-7976 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-477X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association of Lipoprotein-associated Phospholipase A2 Activity with Components of the Metabolic Syndrome in Apparently Healthy Boys
Cardiovascular & Hematological Agents in Medicinal Chemistry Cardio-protective Effects of Glucagon-like Peptide-1 Receptor Agonists: An Overview of Systematic Reviews and Publication Overlap
Current Pharmaceutical Design Aging Liver: Can Exercise be a Better Way to Delay the Process than Nutritional and Pharmacological Intervention? Focus on Lipid Metabolism
Current Pharmaceutical Design Spectrophotometric Quantification of Bilirubin in Hemorrhagic Spinal Fluid using an Innovative Algorithm
Medicinal Chemistry Relevance of Endothelial-Haemostatic Dysfunction in Cigarette Smoking
Current Medicinal Chemistry Imaging of Abdominal Aortic Aneurysm: The Present and the Future
Current Vascular Pharmacology Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression
Current Drug Targets Role of Contrast-Enhanced Ultrasound in the Follow-up of Endo-Vascular Aortic Aneurysm Repair: an Effective and Safe Surveillance Method
Current Pharmaceutical Design Brachial-Ankle Pulse Wave Velocity in the Measurement of Arterial Stiffness: Recent Evidence and Clinical Applications
Current Hypertension Reviews Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued) Efficacy and Safety of Inhaled and Intranasal Corticosteroids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Conserved Domains, Residues, WebLogo and Active Sites of Caspase- Cascades Related to Apoptotic Signaling Pathway
Current Bioinformatics Vitamin D in Chronic Kidney Disease: New Potential for Intervention
Current Drug Targets Targeting Adhesion Molecules in Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets Acute Kidney Injury Post Cardiac Catheterization: Does Vascular Access Route Matter?
Current Cardiology Reviews Immune Modulation as a Therapeutic Strategy for Atherosclerosis
Current Drug Therapy Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats
Protein & Peptide Letters Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Current Drug Safety The Cardiorenal Syndrome: Pathophysiologic Crosstalk, Outcomes, and Treatment Targets
Cardiovascular & Hematological Disorders-Drug Targets Antimicrobial Activity of SPC13, New Antimicrobial Peptide Purified from Scolopendra polymorpha Venom
Anti-Infective Agents